iShares Health Innovation Active ETF Rating $25.13 +0.28 (+1.13%) (As of 12/20/2024 04:32 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsRatings iShares Health Innovation Active ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.74Holdings in BMED have an aggregate rating of Moderate Buy based on 743 analyst ratings issued in the past year covering 44 companies (67.5% of the portfolio).BMED Aggregate Price Target$25.13High Prediction$25.13Average Prediction$25.13Low Prediction$25.13Holdings in BMED have an aggregate price target of $25.13 and a range of $25.13 to $25.13 covering 44 companies (67.5% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 BMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.98%ISRGIntuitive Surgical$524.43+0.1%4.6109 of 5 stars2.74$554.17 5.7%19Analyst ForecastHigh Trading Volume4.62%BSXBoston Scientific$88.95+0.3%4.3364 of 5 stars2.91$95.96 7.9%23Analyst ForecastHigh Trading Volume3.37%ARGXargenx$623.82-0.4%3.0025 of 5 stars2.91$639.78 2.6%22Analyst ForecastShort Interest ↓Positive News2.99%GILDGilead Sciences$92.57+1.6%4.4784 of 5 stars2.67$96.43 4.2%27Insider TradeHigh Trading Volume2.26%ABTAbbott Laboratories$114.23+1.6%4.9149 of 5 stars2.73$130.71 14.4%15Dividend IncreaseHigh Trading Volume2.20%SRPTSarepta Therapeutics$118.97-0.4%4.8572 of 5 stars2.91$178.71 50.2%22Analyst ForecastPositive News2.14%DHRDanaher$228.55+1.1%4.8994 of 5 stars2.79$288.21 26.1%19Analyst ForecastHigh Trading Volume2.06%TECHBio-Techne$73.17+2.5%4.6339 of 5 stars2.63$82.00 12.1%8High Trading Volume1.99%RGENRepligen$144.46-1.4%4.0908 of 5 stars2.62$185.20 28.2%13Analyst ForecastPositive NewsHigh Trading Volume1.86%WATWaters$368.16+2.1%3.7141 of 5 stars2.29$375.85 2.1%14High Trading Volume1.79%NTRANatera$161.88+2.4%2.0775 of 5 stars3.00$152.67 -5.7%15Positive NewsGap DownHigh Trading Volume1.79%EXASExact Sciences$59.40+5.9%4.4883 of 5 stars2.94$72.94 22.8%181.69%PODDInsulet$266.57+3.9%4.241 of 5 stars2.80$269.40 1.1%15Positive News1.61%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.416 of 5 stars2.71$298.09 21.5%24Analyst Upgrade1.60%MDTMedtronic$81.03+1.3%4.9171 of 5 stars2.41$95.00 17.2%17Analyst ForecastOptions Volume1.43%BGNEBeiGene$176.50+1.0%2.6117 of 5 stars2.75$253.69 43.7%81.41%WSTWest Pharmaceutical Services$331.40+1.3%4.966 of 5 stars2.80$437.75 32.1%5High Trading Volume1.40%BMYBristol-Myers Squibb$57.33+1.8%4.7853 of 5 stars2.25$55.64 -2.9%20High Trading Volume1.40%ABBVAbbVie$175.58+2.4%4.9334 of 5 stars2.88$205.70 17.2%24Analyst ForecastInsider TradeHigh Trading Volume1.38%NBIXNeurocrine Biosciences$135.42+0.3%4.8286 of 5 stars2.83$166.00 22.6%23Analyst ForecastInsider TradePositive NewsHigh Trading Volume1.38%TMOThermo Fisher Scientific$524.05+1.4%4.7588 of 5 stars2.86$652.30 24.5%211.32%SNYSanofi$47.71+0.4%3.554 of 5 stars3.00$57.50 20.5%31.31%DXCMDexCom$80.04+5.6%4.9164 of 5 stars2.72$98.00 22.4%18High Trading Volume1.30%RYTMRhythm Pharmaceuticals$56.12+1.2%4.1095 of 5 stars2.90$65.80 17.2%10Analyst ForecastNews CoveragePositive NewsHigh Trading Volume1.13%INSMInsmed$70.44+1.5%2.9718 of 5 stars3.00$83.67 18.8%16Insider TradeHigh Trading Volume1.10%AMGNAmgen$263.38+0.8%4.4622 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume1.08%EWEdwards Lifesciences$74.81+1.2%3.9518 of 5 stars2.42$79.40 6.1%26High Trading Volume1.04%XENEXenon Pharmaceuticals$38.63-0.7%2.789 of 5 stars3.11$56.00 45.0%9Insider TradeHigh Trading Volume1.00%GHGuardant Health$31.67+1.7%4.1203 of 5 stars3.00$40.60 28.2%150.96%AAgilent Technologies$134.51+1.0%4.724 of 5 stars2.43$143.62 6.8%14Analyst ForecastAnalyst RevisionHigh Trading Volume0.95%EXELExelixis$33.29-1.2%4.5006 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume0.94%QGENQiagen$44.67+0.8%3.5166 of 5 stars2.67$51.88 16.1%90.91%PENPenumbra$242.54-0.4%4.2239 of 5 stars2.80$258.00 6.4%15Analyst ForecastHigh Trading Volume0.89%LHLaboratory Co. of America$228.61+0.7%4.9526 of 5 stars2.81$258.62 13.1%16Analyst ForecastPositive News0.88%DNLIDenali Therapeutics$21.45-0.2%4.4228 of 5 stars2.82$40.40 88.3%11Positive NewsHigh Trading Volume0.88%UTHRUnited Therapeutics$359.58-0.2%4.7048 of 5 stars2.73$370.86 3.1%15Analyst DowngradeInsider TradePositive NewsHigh Trading Volume0.87%BPMCBlueprint Medicines$90.14+1.4%2.5681 of 5 stars2.65$123.33 36.8%20Insider Trade0.86%BIIBBiogen$146.47-0.6%4.6286 of 5 stars2.45$242.68 65.7%29Analyst DowngradeHigh Trading Volume0.86%MRUSMerus$41.85-0.6%2.6066 of 5 stars3.14$85.64 104.6%140.82%HOLXHologic$71.65+1.3%4.6664 of 5 stars2.67$89.50 24.9%15Analyst ForecastHigh Trading Volume0.80%SYKStryker$364.60+2.1%4.9541 of 5 stars2.85$405.80 11.3%20Analyst ForecastHigh Trading Volume0.77%IQVIQVIA$197.27+3.0%4.9105 of 5 stars2.90$255.82 29.7%21Analyst ForecastHigh Trading Volume0.74%PFEPfizer$26.36+2.3%4.9711 of 5 stars2.47$32.14 21.9%17Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume0.73%CRLCharles River Laboratories International$185.77+2.0%4.5335 of 5 stars1.93$214.00 15.2%15 This page (NYSEARCA:BMED) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMED Stock Alerts